Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.
about
Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cellsPhase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancerCyclooxygenase-2 confers growth advantage to syngeneic pancreatic cancer cells.Simultaneous knock-down of Bcl-xL and Mcl-1 induces apoptosis through Bax activation in pancreatic cancer cellsInoperable pancreatic cancer patients who have prolonged survival exhibit an increased risk of cholangitis.Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national databaseOxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?Molecular mechanisms of pancreatic cancer and potential targets of treatment.Medical treatment of pancreatic cancer.The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer.The molecular biology of pancreatic cancer.Clinical importance of B7-H3 expression in human pancreatic cancer.Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer--a multi-centre raAccomplishments in 2008 in the treatment of metastatic pancreatic cancer.Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).Management of advanced pancreatic cancer.Baicalein--an intriguing therapeutic phytochemical in pancreatic cancer.Interaction of tumour cells with their microenvironment: ion channels and cell adhesion molecules. A focus on pancreatic cancer.Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy.Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation.Alterations in Pharmacokinetics of Gemcitabine and Erlotinib by Concurrent Administration of Hyangsayukgunja-Tang, a Gastroprotective Herbal Medicine.Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.
P2860
Q24604942-796D41AD-3B1C-4E0E-A225-E2DC512B887BQ34049250-FF3A85B5-C121-4EB1-A823-715612C83268Q34766691-DAE3F647-2EB7-4910-868E-5A7074C3820CQ34802656-8609B8B4-6143-4BCD-8447-B687B32618A3Q34953963-C79E64C3-CC9A-41EB-84CE-5121C478C7E9Q36020628-786D0777-52C7-4261-B726-EC1862294C8DQ36072863-FAF63B77-B951-41D6-A336-B0A593DD7DF5Q36682682-9A23472B-B1A6-4807-81E5-3ED909363DB1Q36758436-4B343F53-019A-4A18-88F1-5E1FA3399797Q36788494-4DB02C2A-69F6-48D7-AD37-3FA77A214A52Q37074126-EDFE1EA4-7684-467D-9ED9-7AD879CB9BCAQ37153303-1CC1E72D-78F4-4F8D-946A-4038A188ADB0Q37424100-D4C73197-ABBF-4B7A-92CE-1DD655B89A06Q37457763-D70DCC00-8D5B-4D68-AF76-FB8320BEFABEQ37468871-209428E3-DA0D-4895-B35B-96C3E05D5F6DQ37569035-C4D7BBD3-250E-4FE0-B26E-BBCAD1AE44A1Q37960190-3018D837-D3EB-4A8B-8022-6BF6A045B248Q38058846-E54CDC43-CC82-4C9A-9AC9-1D37557CD2E0Q38184985-467C88A7-6FD3-4DCD-8877-75F3BAF8B910Q46190697-A9725AFE-E958-4555-9A0D-E7601A522538Q46362755-00DA7BFD-147C-4A36-B0E6-07F6DCFAB8D0Q48004181-33545F49-6880-41E0-91EF-A0056EB5E532Q50943644-3F3BE057-04DD-4C88-A4E2-D88F62BDFB46
P2860
Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Consensus report of the intern ...... in advanced pancreatic cancer.
@ast
Consensus report of the intern ...... in advanced pancreatic cancer.
@en
type
label
Consensus report of the intern ...... in advanced pancreatic cancer.
@ast
Consensus report of the intern ...... in advanced pancreatic cancer.
@en
prefLabel
Consensus report of the intern ...... in advanced pancreatic cancer.
@ast
Consensus report of the intern ...... in advanced pancreatic cancer.
@en
P2093
P356
P1433
P1476
Consensus report of the intern ...... in advanced pancreatic cancer.
@en
P2093
Daniel G Haller
Howard S Hochster
Jaffer A Ajani
Jordan D Berlin
Malcolm J Moore
Philip A Philip
P304
P356
10.1002/CNCR.22036
P407
P577
2006-08-01T00:00:00Z